GB9326425D0 - Vaccine compositions - Google Patents

Vaccine compositions

Info

Publication number: GB9326425D0
Authority: GB; United Kingdom
Prior art keywords: vaccine compositions; vaccine; compositions
Prior art date: 1993-12-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB939326425A

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SECR DEFENCE

UK Secretary of State for Defence

Original Assignee

SECR DEFENCE

UK Secretary of State for Defence

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-24

Filing date

1993-12-24

Publication date

1994-02-23

1993-12-24 Application filed by SECR DEFENCE, UK Secretary of State for Defence filed Critical SECR DEFENCE

1993-12-24 Priority to GB939326425A priority Critical patent/GB9326425D0/en

1994-02-23 Publication of GB9326425D0 publication Critical patent/GB9326425D0/en

1994-12-23 Priority to CA002179639A priority patent/CA2179639A1/fr

1994-12-23 Priority to EP95904620A priority patent/EP0741786A1/fr

1994-12-23 Priority to JP7517658A priority patent/JPH09507028A/ja

1994-12-23 Priority to AU13222/95A priority patent/AU1322295A/en

1994-12-23 Priority to PCT/GB1994/002818 priority patent/WO1995018231A1/fr

Status Pending legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Plant Pathology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Physics & Mathematics (AREA)
Oncology (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

GB939326425A 1993-12-24 1993-12-24 Vaccine compositions Pending GB9326425D0 (en)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
GB939326425A GB9326425D0 (en)	1993-12-24	1993-12-24	Vaccine compositions
CA002179639A CA2179639A1 (fr)	1993-12-24	1994-12-23	Compositions pour vaccins comprenant des vecteurs bacteriens vivants pour la protection contre l'infection a yersinia pestis
EP95904620A EP0741786A1 (fr)	1993-12-24	1994-12-23	Compositions pour vaccins comprenant des vecteurs bacteriens vivants pour la protection contre l'infection a yersinia pestis
JP7517658A JPH09507028A (ja)	1993-12-24	1994-12-23	イエルシニアペスチス（Ｙｅｒｓｉｎｉａｐｅｓｔｉｓ）感染から防御するための生細菌ベクターを含むワクチン組成物
AU13222/95A AU1322295A (en)	1993-12-24	1994-12-23	Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection
PCT/GB1994/002818 WO1995018231A1 (fr)	1993-12-24	1994-12-23	Compositions pour vaccins comprenant des vecteurs bacteriens vivants pour la protection contre l'infection a yersinia pestis

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939326425A GB9326425D0 (en)	1993-12-24	1993-12-24	Vaccine compositions

Publications (1)

Publication Number	Publication Date
GB9326425D0 true GB9326425D0 (en)	1994-02-23

Family

ID=10747201

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB939326425A Pending GB9326425D0 (en)	1993-12-24	1993-12-24	Vaccine compositions

Country Status (6)

Country	Link
EP (1)	EP0741786A1 (fr)
JP (1)	JPH09507028A (fr)
AU (1)	AU1322295A (fr)
CA (1)	CA2179639A1 (fr)
GB (1)	GB9326425D0 (fr)
WO (1)	WO1995018231A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2197988C2 (ru) *	1995-03-13	2003-02-10	Дзе Секретэри Оф Стейт Фор Дефенс	Противочумная вакцина
US20070043215A1 (en) *	1996-08-27	2007-02-22	Heath David G	Recombinant f1-v plague vaccine
AU5597998A (en) *	1996-12-04	1998-06-29	Heska Corporation	Recombinant plague vaccine
US6977245B2 (en)	1999-04-12	2005-12-20	The United States Of America As Represented By The Department Of Health And Human Services	Oligodeoxynucleotide and its use to induce an immune response
WO2000061151A2 (fr) *	1999-04-12	2000-10-19	The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Un oligodesoxynucleotide et son emploi pour induire une reponse immunitaire
GB9921275D0 (en) *	1999-09-10	1999-11-10	Secr Defence	Recombinant microorganisms
ATE378348T1 (de)	2000-01-14	2007-11-15	Us Health	Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
WO2003020884A2 (fr)	2001-08-14	2003-03-13	The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services	Procede de generation rapide de cellules dentritique matures
US7615227B2 (en)	2001-12-20	2009-11-10	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Use of CpG oligodeoxynucleotides to induce angiogenesis
GB0220257D0 (en)	2002-08-31	2002-10-09	Secr Defence	Vaccine
US7344718B2 (en)	2003-01-31	2008-03-18	University Of North Dakota	Yersinia species compositions
WO2012178078A2 (fr)	2011-06-22	2012-12-27	University Of North Dakota	Utilisation d'une yscf, d'une yscf tronquée et d'homologues de l'yscf comme adjuvants
IN2014DN09618A (fr)	2012-05-23	2015-07-31	Us Sec Dep Of Health And Human Services

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0474891A1 (fr) *	1990-09-08	1992-03-18	BEHRINGWERKE Aktiengesellschaft	Vecteurs pour l'expression d'antigènes malariales sur la surface de souches vaccinales de Salmonella
JP3601602B2 (ja) *	1990-11-09	2004-12-15	ワシントンユニバーシティ	無毒性微生物及びその使用：サルモネラ

1993
- 1993-12-24 GB GB939326425A patent/GB9326425D0/en active Pending
1994
- 1994-12-23 EP EP95904620A patent/EP0741786A1/fr not_active Withdrawn
- 1994-12-23 AU AU13222/95A patent/AU1322295A/en not_active Abandoned
- 1994-12-23 WO PCT/GB1994/002818 patent/WO1995018231A1/fr not_active Ceased
- 1994-12-23 CA CA002179639A patent/CA2179639A1/fr not_active Abandoned
- 1994-12-23 JP JP7517658A patent/JPH09507028A/ja active Pending

Also Published As

Publication number	Publication date
CA2179639A1 (fr)	1995-07-06
WO1995018231A1 (fr)	1995-07-06
EP0741786A1 (fr)	1996-11-13
JPH09507028A (ja)	1997-07-15
AU1322295A (en)	1995-07-17

Publication	Publication Date	Title
AP9400629A0 (en)	1994-04-30	Vaccine compositions
AP9300502A0 (en)	1993-04-30	Vaccine compositions
IL118004A0 (en)	1996-08-04	Vaccine compositions
PL315128A1 (en)	1996-10-14	Anti-pollutant compositions
IL110665A0 (en)	1994-11-11	Erection-inducing compositions
ZA961460B (en)	1996-08-29	Vaccine compositions
AP9400621A0 (en)	1994-04-30	Influenza vaccine compositions
GB9318641D0 (en)	1993-10-27	Compositions
PL313979A1 (en)	1996-08-05	Vaccine composition
GB9323313D0 (en)	1994-01-05	Clenasing compositions
GB9326425D0 (en)	1994-02-23	Vaccine compositions
GB9304823D0 (en)	1993-04-28	Cable-making compositions
PL311721A1 (en)	1996-03-04	Compositions
GB9313759D0 (en)	1993-08-18	Cementiferous compositions
GB9306029D0 (en)	1993-05-12	Vaccine compositions
GB9320454D0 (en)	1993-11-24	Vaccine compositions
GB9323820D0 (en)	1994-01-05	Vaccine
GB9425980D0 (en)	1995-02-22	Vaccine compositions
GB9601739D0 (en)	1996-03-27	Vaccine Compositions
GB9416097D0 (en)	1994-09-28	Vaccine compositions
GB9403417D0 (en)	1994-04-13	Vaccine compositions
GB9324743D0 (en)	1994-01-19	Adjuvant compositions
GB9314206D0 (en)	1993-08-18	Compositions
GB9306033D0 (en)	1993-05-12	Compositions
GB9304400D0 (en)	1993-04-21	Pharmaceuticla compositions